journal article·2009-08

Highly Porous Nano‐ and Microstructured Films Loaded with Bioactive Agents for Biomedical Applications: Structure—Release Profile Effects

Adi Rachelson, Meital Zilberman

Advanced Engineering Materials· Volume 11· Issue 8
Publisher page

Abstract

The current study focuses on the nanostructuring of our new drug-eluting porous films and its effect on the drug release profile of both hydrophilic and hydrophobic drugs. Nanostructuring was obtained using both the dispersion and the condensation methods of emulsion processing. These new highly porous nanostructured films can be used as basic elements of various drug-eluting medical devices.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Drug Solubulity and Delivery Systems · Surfactants and Colloidal Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (20)

Show source-provided references
1. Bibette J. · 200210.1007/3-540-70820-0 ↗
2. 10.2174/15672010577437026710.2174/156720105774370267 ↗
3. 10.1021/la001362n10.1021/la001362n ↗
4. 10.1002/ceat.20040611110.1002/ceat.200406111 ↗
5. 10.1016/j.colsurfa.2004.03.03910.1016/j.colsurfa.2004.03.039 ↗
6. 10.1016/j.ejpb.2005.05.00410.1016/j.ejpb.2005.05.004 ↗
7. 10.1021/jp061636110.1021/jp0616361 ↗
8. 10.1016/S0142-9612(00)00122-810.1016/S0142-9612(00)00122-8 ↗
9. 10.1016/j.cis.2006.05.02110.1016/j.cis.2006.05.021 ↗
10. 10.1016/S0142-9612(00)00178-210.1016/S0142-9612(00)00178-2 ↗
11. 10.1016/S0168-3659(02)00176-110.1016/S0168-3659(02)00176-1 ↗
12. 10.1211/jpp.57.10.000410.1211/jpp.57.10.0004 ↗
13. 10.1016/S0939-6411(00)00109-010.1016/S0939-6411(00)00109-0 ↗
14. 10.1016/S0378-5173(99)00087-310.1016/S0378-5173(99)00087-3 ↗
15. 10.1056/NEJMoa03244110.1056/NEJMoa032441 ↗
16. 10.1056/NEJM19950413332150710.1056/NEJM199504133321507 ↗
17. 10.1016/j.semcancer.2004.04.00410.1016/j.semcancer.2004.04.004 ↗
18. A.Stokley http://www.fda.gov/medwatch/SAFETY/2004/may_PI/Fortaz_PI.pdf 2004 NDA 50‐578/S‐040.
19. Mylan Pharmaceuticals http://www.fda.gov/cder/foi/label/1998/19832lbl.pdf 1998 NDA 19‐832.
20. 10.1016/j.actbio.2006.06.00810.1016/j.actbio.2006.06.008 ↗